Document is current
Any future updates will be listed below
-
Authors
Li, LeeAnn K.
Huang, Wen-Chin
Hsueh, Yuan-Yu
Yamauchi, Ken
Olivares, Natalie
Davila, Raul
Fang, Jun
Ding, Xili
Zhao, Weikang
Soto, Jennifer
Hasani, Mahdi
Novitch, Bennett
-
Funding
Funding for this research was provided by:
National Institutes of Health (HL121450, GM008042, NS126918)
University of California, Los Angeles (Startup Fund)
- License Information
-
More Information
Article History
Received: 2 October 2021
Accepted: 28 March 2022
First Online: 16 May 2022
Declarations
:
: Rat studies were approved by the UCLA Institutional Animal Care and Use Committee (IACUC), known locally as the Chancellor’s Animal Research Committee (ARC), under Protocol ARC-2016-101. Human mesenchymal stem cells (hMSCs) were obtained from Texas A&M Health Science Centre College of Medicine through a grant obtained from NCRR of the NIH (P40RR017447). Cells were received with no identifying patient information. The cells are obtained from normal, healthy volunteers pre-screened for infectious diseases under a protocol approved by both the Scott & White and Texas A&M University IRBs with written informed consent.
: Not applicable; there are no data involving any individual person’s data.
: The authors declare that they have no competing interests.
